Treatment of bone disorders with skeletal anabolic drugs

Details for Australian Patent Application No. 2005287139 (hide)

Owner Osteotrophin LLC

Inventors Stewart, Andrew F.

Agent Davies Collison Cave

Pub. Number AU-A-2005287139

PCT Pub. Number WO2006/033912

Priority 60/610,283 16.09.04 US

Filing date 14 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/033912 Priority application(s): WO2006/033912

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287144-Polytrimethylene terephthalate having a low level of acrolein and a process for producing the same

2005287137-Compounds, compositions and methods of inhibiting a-synuclein toxicity